Episode 314: APCCC 2024 - Cardiovascular Risks With Hormone Therapy in Prostate Cancer

By The Uromigos - Last Updated: April 30, 2024

Professor Thomas Suter and Dr. Chuck Ryan join Brian and Tom at APCCC 2024 to discuss the cardiovascular risks associated with hormone therapy use in prostate cancer.

Professor Suter leads the Cardio-Oncology Service at Bern University Hospital, and Dr. Ryan is a clinician-scientist and president of the Prostate Cancer Foundation.

Post Tags:Uromigos-Prostate Cancer
Advertisement
Advertisement
Advertisement